User: stemcellpatents |
Hematopoietic and mesenchymal stem cells into pancreas for more info see www.stemcellpatents.com Tags: Stem Cells Mesenchymal Hematopoietic pancreatic insulin diabetes |
User: pauloyahoo |
Transplante células tronco medula óssea sem hemocomponentes Brazil - Hematopoietic stem cell transplantation without the use of blood transfusions. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842006000200018&lng=&nrm=iso&tlng= http://www.openj-gate.com/abstract.asp?articleid=8378402 Transplante autólogo de células-tronco hematopoiéticas sem uso de hemocomponentes. Descrevemos um caso de paciente Testemunha de Jeová, portadora de linfoma Hodgkin, que foi submetida a infusão de células-tronco hematopoéticas sem o uso de hemocomponentes. O curso do transplante transcorreu sem complicações graves. Este caso demonstra que o transplante autólogo de células-tronco hematopoéticas sem o uso de hemocomponentes é factível em situações especiais, onde há clara expressão do desejo do paciente associado a condições clínicas favoráveis e acompanhamento médico especialista rigoroso. ABSTRACT - Hematopoietic stem cell transplantation (HSCT) is standard therapy for the treatment of some hematological neoplasms and support with blood transfusions is considered essential for this procedure. Herein we describe the case of a Jeovah's witness who had Hodgkin's lymphoma in third partial remission and was submitted to with posterior infusion of autologous peripheral blood stem cells without the use of blood transfusions. This report shows that the autologous peripheral blood stem cell transplantation without the use of blood and platelet transfusions is feasible in special situations, where patients clearly express their wishes and where there is a favorable clinical condition with rigorous medical care provided by specialists. Por motivações religiosas, cerca de 1.600.000 pessoas no Brasil, recusam-se a receber transfusão sangüínea e ficam, portanto, excluídas da possibilidade de receber diversas terapias, principalmente procedimentos cirúrgicos. Ballen et al. e Mazza et al. relataram casos de transplante de medula óssea realizados sem o uso de hemocomponentes com toxicidade relacionada ao tratamento semelhante aos descritos na literatura. Não pretendemos neste relato discutir os aspectos religiosos envolvidos na questão. No entanto, é de conhecimento da comunidade médica que cerca de 6 milhões de pessoas no mundo são adeptas do grupo religioso Testemunhas de Jeová, que não aceitam transfusão de sangue total ou hemocomponentes (glóbulos vermelhos, glóbulos brancos, plaquetas ou plasma), sendo que o uso de alguns hemoderivados (ou frações sangüíneas como albumina, imunoglobulinas e fatores de coagulação) podem ser aceitos por alguns destes pacientes. Este aspecto certamente tem excluído muitos destes cidadãos de um tratamento adequado em diversos centros médicos no Brasil. Este é, segundo o nosso conhecimento, o primeiro caso relatado de TCTH sem o uso de transfusão sangüínea realizado com sucesso em criança e o primeiro relato no Brasil. A objeção pessoal à transfusão sangüínea, antes de representar um obstáculo ao tratamento médico adequado, pode representar um desafio para o desenvolvimento de alternativas terapêuticas, contribuindo assim para o avanço da medicina. Conclusão O transplante autólogo de células-tronco hematopoéticas sem o uso de hemocomponentes é factível em situações especiais, onde há clara expressão do desejo do pacien te associado a condições clínicas favoráveis e acompanhamento médico especialista rigoroso. http://www.scielo.br/pdf/rbhh/v28n2/v28n2a18.pdf http://pt.wikipedia.org/wiki/Alternativas_m%C3%A9dicas_ao_sangue http://www.watchtower.org/t/medical_care_and_blood.htm Tags: Transplante células-tronco blood transfusions stem cell Jeová Jehovah's Jehova Geova |
User: penguin6636 |
Stem Cells and Beyond Part 1 A projcect for immunolgy about hematopoietic stem cells, part 1 of 2 Tags: hematopoietic stem cells beyond |
User: penguin6636 |
Stem Cells and Beyond Part 2 A projcect for immunolgy about hematopoietic stem cells, part 2 of 2 Tags: hematopoietic stem cells beyond |
User: incredibleleo |
Margination and Rolling of Hematopoeitic Progenitors in the Murayama E, et al Tracing Hematopoietic Precursor Migration to Successive Hematopoietic Organs during Zebrafish Development, ImmunityVolume 25, Issue 6, , December 2006, Pages 963-975 Tags: Haematopoesis |
User: cellmedicine |
Bone Marrow Stem Cells www.cellmedicine.com Tags: stem cell therapy bone marrow hematopoietic clinic differentiation transplant autism regenerative medicine mesenchymal |
User: cellmedicine |
Stem Cell Types and Sources www.cellmedicine.com Tags: bone marrow stem cells mesenchymal cord blood placental hematopoietic transplant cerebral palsy autism leukemia clinic |
User: cellmedicine |
Evidence of Stem Cell Benefits www.cellmedicine.com Tags: stem cell cells bone marrow hematopoietic diabetes liver heart failure autism regeneration myocardium infarct attack |
User: incredibleleo |
Haematopoietic cell precursor at Caudal vein plexus Murayama E, et al Tracing Hematopoietic Precursor Migration to Successive Hematopoietic Organs during Zebrafish Development, ImmunityVolume 25, Issue 6, , December 2006, Pages 963-975. Tags: haematopoeisis |
User: Minee32 |
Zebrafish hematopoiesis: the definitive wave A brief animation describing the induction of hematopoietic stem cells in the zebrafish. Tags: zebrafish hematopoiesis |
User: allyoumed |
Brian's Stem Cell/Chemo Recovery Page from MS Videos of my recovery from Hematopoietic Stem Cell Transplant procedure. Tags: Allyoumed Multiple Sclerosis MS Brian Tilaro recovery |
User: cellmedicine |
Bone Marrow Producing Insulin www.cellmedicine.com a description of the publication In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes. 2004 Jul;53(7):1721-32 Tags: diabetes diabetic mellitus type 2 stem cells bone marrow cell therapy clinic clinical trial hematopoietic mesenchymal |
User: USCViterbi |
Research Symposium: Mork Department - 2007 - Video 4 Mork Family Department of Chemical Engineering and Materials Science Second Annual graduate student research symposium October 23, 2007 - Targeted gene delivery to hematopoietic stem cells by Leslie Bailey and Pin Wang Tags: University of Southern California Viterbi School Engineering Mark Family Department |
User: URIanimation |
Gleevecs mechanism of Action The animation begins by introducing the Philadelphia Chromosome, the result of a reciprocal translocation between chromosomes 9 and 22. More specifically the breakpoint cluster region (BCR) of chromosome 22 is fused with part of the Abelson (ABL) gene on chromosome 9. The resulting BCR-ABL genetic domain now located within chromosome 22 and codes for a mutant tyrosine kinase also known as BCR-ABL. Under normal circumstances tyrosine kinase proteins respond to external cellular messaging proteins, and ultimately initiate a series of reactions that culminate in cellular replication. Conversely, BCR-ABL is constitutively active, meaning it does not require activation by the aforementioned cellular messaging proteins in order to stimulate cellular replication. This results in acceleration of cell division, an inhibition of DNA repair, overall genomic instability, and the fatal blast crisis characteristic of chronic myelogenous leukemia. The animation progresses to introduce Gleevec (imatinib), the first in a class of drugs that specifically target and competively inhibit the ATP binding site on BCR-ABL tyrosine kinase. This prevents the ABL domain from phosphorylating the tyrosine residue, and as a result preventing the proliferation of hematopoietic cells that express BCR-ABL. Therapy with imatinib results in a dramatic reduction of tumor clone cells and the occurrence of blast crisis', through targeted drug treatment which leaves health cells unscathed. Created by: Nelson Caetano Class of 2007 Pharmacy Dr. Bongsup Cho Professor of Biomedical and Pharmaceutical Sciences College of Pharmacy Tags: Gleevec Glivec mechanism of Action Drug Chronic Myologenous Leukemia Cancer URI animation |
User: samitivej |
Bone marrow transplant (BMT) Bone marrow transplantation (BMT) is a relatively new medical procedure being used to treat diseases once thought incurable. Tags: Bone marrow transplant transplantation leukemia aplastic anemia lymphomas Thalassemia Anemia Hematopoietic |
User: USCViterbi |
Research Symposium: Mork Depart - 2006 - Video 1 Mork Family Department of Chemical Engineering and Materials Science Second Annual graduate student research symposium October 20, 2006 - Targeting Lentivectors to CD34+Hematopoietic Stem Cells (HSCs) for Gene Therapy by Leslie Bailey and Pin Wang Tags: University of Southern California Viterbi School Engineering Mark Family Department |
User: frantraf |
Crawling Neutrophil chasing bacterium (Fagocitando bacteria) Crawling Neutrophil chasing a Bacterium (Un glóbulo blanco persigue a una bacteria) White blood cells, or leukocytes, are cells of the immune system defending the body against both infectious disease and foreign materials. Several different and diverse types of leukocytes exist, but they are all produced and derived from a multipotent cell in the bone marrow known as a hematopoietic stem cell. Leukocytes are found throughout the body, including the blood and lymphatic system. The number of leukocytes in the blood is often an indicator of disease. There are normally between 4×109 and 11×109 white blood cells in a litre of blood, making up approximately 1% of blood in a healthy adult. In conditions such as leukemia, the number of leukocytes is higher than normal, and in leukopenia, this number is much lower. The physical properties of leukocytes, such as volume, conductivity, and granularity, may change due to activation, the presence of immature cells, or the presence of malignant leukocytes in leukemia. Neutrophil Neutrophils defend against bacterial or fungal infection and other very small inflammatory processes that are usually first responders to microbial infection; their activity and death in large numbers forms pus. They are also known as polymorphonuclear leukocytes. They have a multilobed nucleus which may appear like multiple nuclei, hence the name polymorphonuclear leukocyte. The cytoplasm may look transparent because of fine granules that are faintly pink in color. Neutrophils are very active in phagocytosing bacteria and are present in large amount in the pus of wounds. These cells are not able to renew their lysosomes used in digesting microbes and die after having phagocytosed a few pathogens. Source: Wikipedia.org -------------------- Tags: Immune Neutrophil Eosinophil Basophil Lymphocyte Monocyte Macrophage White blood cell bacterium bacteria fagocitar |
User: HUNDREDSSHA |
山东小伙为韩国人捐献救命干细胞 山东小伙为韩国人捐献救命干细胞 A Shandongnese donated his Hematopoietic stem cells to patients from South Korea Tags: 山东 山東 Shandong China Korea SouthKorea 산동 중국 韩国 棒子 捐献 中国 |
User: ncbookz |
PREVENTION AND CURE OF CANCER HAS BEEN AROUND A WHILE http://www.ncbookz.com IS WHERE THE RESEARCH IS LOCATED. NOTE: I NOTICED SOME SPELLING ERRORS IN THE VIDEO AFTER I UPLOADED I WILL REDO AT A LATER DATE --------------------------------------- THEY HAVE LIED TO US ONCE AGAIN AFTER 1 YEAR I HAVE CONCLUDED THAT THE CURE HAS BEEN HERE FOR 7000 YEARS NO DOUBT NO LIE NO JOKE GO TO WWW.NCBOOKZ.COM AND YOU CAN GET THE RESEARCH I HAVE DONE. MY ADMINISTRATOR WILL GET THE INFORMATION TO YOU. I DON'T HAVE THE TIME TO CHAT ABOUT THIS WITH YOU BUT WE DO HAVE IT ALL IN EMAIL FORM AND SHE CAN PDF THIS OR EMAIL IT TO YOU THANKS AGAIN I AM SURE OF WHAT I AM SAYING HERE FRIENDS THE WHITE BLOOD CELLS ATTACK THE CANCER CELLS ONLY WHEN THE BLOOD IS AT ITS RIGHT LEVEL AND STRENGTH. White blood cells, or leukocytes, are cells of the immune system defending the body against both infectious disease and foreign materials. Several different and diverse types of leukocytes exist, but they are all produced and derived from a multipotent cell in the bone marrow known as a hematopoietic stem cell. Leukocytes are found throughout the body, including the blood and lymphatic system. The number of leukocytes in the blood is often an indicator of disease. There are normally between 4×109 and 11×109 white blood cells in a litre of blood, making up approximately 1% of blood in a healthy adult. In conditions such as leukemia, the number of leukocytes is higher than normal, and in leukopenia, this number is much lower. The physical properties of leukocytes, such as volume, conductivity, and granularity, may change due to activation, the presence of immature cells, or the presence of malignant leukocytes in leukemia. THE ABOVE IS ONE SENTENCE FROM SOME OF MY RESEARCH IT GETS EVEN DEEPER YOUWILLBE SHOCKED I EVEN SHOW YOU WHAT FOODS RAISE PH AND TO THE 7.4 YOUR BLOOD NEEDS TO BE AT! IT IS SO FUNNY HOW DOCTORS WITH SO MUCH LEARNING, LET THESE MANAGEMENT COMPANIES TELL THEM IT IS ILLEGAL TO GIVE NATURAL HEALING ADVICE THE TRUE TRAITORS ARE THE DOCTORS, PHARMACIST, POLITICIANS AND LAWYERS WHO MAKE SO MANY LAWS AND RULES THAT THEY CAN'T KEEP THEM NOR CAN YOU. IN REVELATION IT SAYS THE LEAVES WILL BE FOR THE HEALING OF THE NATIONS. I DO NOT DISCOUNT DOCTORS BUT I DISCOUNT DOCTORS WHO THINK A PILL HEALS BECAUSE ONLY THE BODY CAN HEAL ITSELF WITH PROPER BLOOD CHEMISTRY. 7.4 PH AND HIGH OXYGEN CONTENT. WITH WHAT IS IT 11 SYSTEMS IN YOUR BODY THE ONLY ONE YOU CAN CONTROL IS DIGESTION SO WHEN YOU REST THIS SYSTEM YOU PUT MORE POWER IN YOUR IMMUNE SYSTEM. THIS IS ALL YOU NEED TO KNOW FRIENDS TO BE HEALTHY THIS RESEARCH IS EVERYTHING YOU NEED. I HAVE NOT BEEN SICK SINCE I FOUND OUT THIS MYSTERY. EVEN WITH FOOD POISONING I APPPLIED A WATER FAST AND I NEVER EXPELLED ANY FOOD THE WATER DILUTED EVERYTHING AND THE FASTING SENT EXTRA NEEDED STRENGTH TO MY IMMUNE SYSTEM AND WITHIN 8 HOURS I WAS FEELING 100%. I NOTICED THE POISONING THE 1ST 2 HOURS AND THEN I WENT THROUGH A GALLON OF WATER OVER THE NEXT 8 HOURS WITH NO FOOD AND ALLWAS WELL. YOU KNOW WHEN YOUR BODY IS BEING ATTACKED BY A VIRUS OR POISON AND AS SOON AS YOU FEEL THIS STOP EATING REST AND DRINK WATER. IF ITIS NOT POISONING DRINK LEMONAID THIS RAISES YOUR PH UP BECAUSE MOST THE FAST FOOD DROPS IT SO LOW WE NEED HIGH ACIDIC TO SHOCK OUR BODY INTO THE REVERSE. IT IS IN THE RESEARCH PAPERS IT IS KINDA OPPOSITE SOUNDING BUT IT WORKS. DID YOU KNOW YOU STOMACH HAS MORE ACID IN IT THAN A CAR BATTERY? FOR REAL NOTHING THAT GOES INTO YOUR STOMACH WILL SURVIVE SO QUIT WORRYING SO MUCH ABOUT WHAT GFOES INTO THE BODY AS JESUS SAID AND WORRY MORE ABOUT WHAT COMES OUT OF THE HEART. FORGIVE REST PRAY OH I FORGOT THE PRAYER PART THIS GOES ALONG WITH FASTING FRIENDS AND NEVER NEVER FORGET JOHN 3:16 Tags: HEALTH CANCER MEDICINE NATURAL TRUTH |
User: rosaryfilms |
Adult Stem Cell Results & Embryonic Stem Cell Ethics Video Adult Stem Cell Research: Making a Difference Today from Rosenberg Communications, Inc. The Gerard Health Foundation has produced a powerful video on adult stem cell research, showing its advantages over embryonic stem cell research. The public domain video offers useful, yet often ignored, information about adult stem cell research. We believe the information you'll see in the video is essential to making an informed judgment about the debate over this research. This film is consistent with the teachings of the Roman Catholic Church, which state that the ablation of the inner cell mass (ICM) of the blastocyst, which critically and irremediably damages the human embryo, curtailing its development, is a gravely immoral act and consequently is gravely illicit. No end believed to be good, such as the use of stem cells for the preparation of other differentiated cells to be used in what look to be promising therapeutic procedures, can justify an intervention of this kind. A good end does not make right an action which in itself is wrong. An adult stem cell is an undifferentiated cell found among differentiated cells in a tissue or organ, can renew itself, and can differentiate to yield the major specialized cell types of the tissue or organ. The primary roles of adult stem cells in a living organism are to maintain and repair the tissue in which they are found. Some scientists now use the term somatic stem cell instead of adult stem cell. Unlike embryonic stem cells, which are defined by their origin (the inner cell mass of the blastocyst), the origin of adult stem cells in mature tissues is unknown. Research on adult stem cells has recently generated a great deal of excitement. Scientists have found adult stem cells in many more tissues than they once thought possible. This finding has led scientists to ask whether adult stem cells could be used for transplants. In fact, adult blood forming stem cells from bone marrow have been used in transplants for 30 years. Certain kinds of adult stem cells seem to have the ability to differentiate into a number of different cell types, given the right conditions. If this differentiation of adult stem cells can be controlled in the laboratory, these cells may become the basis of therapies for many serious common diseases. The history of research on adult stem cells began about 40 years ago. In the 1960s, researchers discovered that the bone marrow contains at least two kinds of stem cells. One population, called hematopoietic stem cells, forms all the types of blood cells in the body. A second population, called bone marrow stromal cells, was discovered a few years later. Stromal cells are a mixed cell population that generates bone, cartilage, fat, and fibrous connective tissue. Also in the 1960s, scientists who were studying rats discovered two regions of the brain that contained dividing cells, which become nerve cells. Despite these reports, most scientists believed that new nerve cells could not be generated in the adult brain. It was not until the 1990s that scientists agreed that the adult brain does contain stem cells that are able to generate the brain's three major cell types—astrocytes and oligodendrocytes, which are non-neuronal cells, and neurons, or nerve cells. Public domain film from: From http://h1.ripway.com/rosenbergComm/. (public domain). Tags: stem cell cells research embryonic adult ethics morality cloning therapeutic nuclear transfer embryo blastocyst SCNT ESC |
User: samsungselina |
Founder of CMDP 林瑞班_全国首家无偿献血志愿者协会创立者 Founder of CMDP 林瑞班. The Data Bank of Chinese Hematopoietic Stem Cell Donors is also known as Chinese Marrow Donor Program (CMDP), which is a public welfare organization under the leadership of Red Cross Society of China. 先后获得全国十大社会公益之星、中华慈善奖、全国无偿献血奉献奖金奖、全国无偿献血促进奖、中国优秀青年志愿者、省十大杰出青年志愿者等荣誉。 Tags: Torch Olympic Samsung 三星, 火炬手, 奥运 |
User: incredibleleo |
Blood circulation in caudal vein plexus in zerbrafish Murayama E et al . Tracing Hematopoietic Precursor Migration to Successive Hematopoietic Organs during Zebrafish Development, ImmunityVolume 25, Issue 6, , December 2006, Pages 963-975. Tags: Hsematopoiesis |
User: incredibleleo |
Granulocyte in the Caudal Hematopoeitic Tissue at 4 dpf Murayama E, et al Tracing Hematopoietic Precursor Migration to Successive Hematopoietic Organs during Zebrafish Development, ImmunityVolume 25, Issue 6, , December 2006, Pages 963-975. Tags: Developmental biology |
User: MultiVuOnline |
FDA APPROVES NOXAFIL® ORAL SUSPENSION FOR PREVENTION OF LIFE FDA APPROVES NOXAFIL® ORAL SUSPENSION FOR PREVENTION OF LIFE-THREATENING FUNGAL INFECTIONS IN HIGH-RISK PATIENTS In the U.S., each year more than 1.3 million hospital patients are affected by invasive fungal infections (IFIs). Once these infections are established in high-risk patients, such as stem cell transplant recipients or other cancer patients receiving chemotherapy, they are extremely difficult to treat and have a high mortality rate (60-90 percent.) Worldwide, there is an unmet need for new ways to prevent IFIs in these high-risk patients given the increased incidence of fungal resistance to currently available therapies. Schering-Plough has received FDA approval for NOXAFIL® (posaconazole) Oral Suspension for prophylaxis (prevention) of invasive Aspergillus and Candida infections in patients 13 years of age and older who are at high risk of developing these infections due to being severely immunocompromised, such as hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD) or those with hematologic malignancies with prolonged neutropenia from chemotherapy. NOXAFIL is a novel triazole antifungal agent discovered and developed by Schering-Plough Research Institute. For more go to www.schering-plough.com. Tags: FUNGAL PREVENTION INFECTIONS cancer patients NOXAFIL Multivu 24451 |
User: cellmedicine |
Homing of Stem Cells to Target Tissue www.cellmedicine.com Tags: stem cells homing bone marrow cord blood hematopoiesis anormed sdf-1 stromal derived factor diabetes parkinsons leukemia |